ZA814925B - Formulations of heterocyclic compounds - Google Patents

Formulations of heterocyclic compounds

Info

Publication number
ZA814925B
ZA814925B ZA814925A ZA814925A ZA814925B ZA 814925 B ZA814925 B ZA 814925B ZA 814925 A ZA814925 A ZA 814925A ZA 814925 A ZA814925 A ZA 814925A ZA 814925 B ZA814925 B ZA 814925B
Authority
ZA
South Africa
Prior art keywords
formulations
heterocyclic compounds
heterocyclic
compounds
Prior art date
Application number
ZA814925A
Other languages
English (en)
Inventor
T Jones
A White
Original Assignee
Wellcome Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Found filed Critical Wellcome Found
Publication of ZA814925B publication Critical patent/ZA814925B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Virology (AREA)
  • Dispersion Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
ZA814925A 1980-07-18 1981-07-17 Formulations of heterocyclic compounds ZA814925B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB8023645 1980-07-18

Publications (1)

Publication Number Publication Date
ZA814925B true ZA814925B (en) 1983-02-23

Family

ID=10514892

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA814925A ZA814925B (en) 1980-07-18 1981-07-17 Formulations of heterocyclic compounds

Country Status (6)

Country Link
US (1) US4963555A (enExample)
JP (1) JPH0148885B2 (enExample)
KR (1) KR830005852A (enExample)
GE (1) GEP19981256B (enExample)
SU (1) SU1375113A3 (enExample)
ZA (1) ZA814925B (enExample)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9001886D0 (en) * 1990-01-26 1990-03-28 Beecham Group Plc Pharmaceutical formulation
GB9315755D0 (en) * 1993-07-30 1993-09-15 Wellcome Found Stabilized formulation
GB9826656D0 (en) 1998-12-03 1999-01-27 Novartis Ag Organic compounds
US6653318B1 (en) 1999-07-21 2003-11-25 Yale University 5-(E)-Bromovinyl uracil analogues and related pyrimidine nucleosides as anti-viral agents and methods of use
US20050058673A1 (en) 2003-09-09 2005-03-17 3M Innovative Properties Company Antimicrobial compositions and methods
BRPI0414193A (pt) * 2003-09-09 2006-10-31 3M Innovative Properties Co composição antimicrobiana, kit antimicrobiano e métodos de usar a composição e de aplicar uma composição antimicrobiana a um substrato
WO2005067941A1 (es) * 2004-01-08 2005-07-28 Universidad De Concepcion Formulacion topica de aciclovir
US9028852B2 (en) * 2004-09-07 2015-05-12 3M Innovative Properties Company Cationic antiseptic compositions and methods of use
US20060051384A1 (en) * 2004-09-07 2006-03-09 3M Innovative Properties Company Antiseptic compositions and methods of use
US8198326B2 (en) * 2004-09-07 2012-06-12 3M Innovative Properties Company Phenolic antiseptic compositions and methods of use
BRPI0608690B8 (pt) 2005-03-10 2021-05-25 3M Innovative Properties Co uso de uma composição antimicrobiana
BRPI0608691A2 (pt) 2005-03-10 2010-12-07 3M Innovative Properties Company composição antimicrobiana, e, métodos para matar ou inativar microorganismos em tecido da mucosa de um mamìfero, para tratar uma lesão ou ferimento infectado, para descolonização de microorganismos, para proporcionar eficácia antimicrobiana residual sobre uma superfìcie e para tratar uma condição
WO2006099325A2 (en) 2005-03-10 2006-09-21 3M Innovative Properties Company Methods of treating ear infections
US8771712B2 (en) * 2006-05-09 2014-07-08 Emisphere Technologies, Inc. Topical administration of acyclovir
JP4972062B2 (ja) * 2008-03-17 2012-07-11 メディヴィル・アクチエボラーグ 抗ウイルス製剤
US8236768B2 (en) 2008-10-03 2012-08-07 3B Pharmaceuticals, Inc. Topical antiviral formulations
US8853223B2 (en) * 2010-09-17 2014-10-07 G2L Touch, Inc. Therapeutic composition to treat lesions caused by herpes simplex virus
WO2011035120A2 (en) * 2009-09-17 2011-03-24 Gk Ventures, L.L.C. Therapeutic composition to treat lesions caused by herpes simplex virus
RU2457843C1 (ru) * 2011-05-11 2012-08-10 Общество с ограниченной ответственностью фирма "Вита" Стабилизированный фармацевтический состав с противовирусным действием
WO2013077881A1 (en) 2011-11-23 2013-05-30 3B Pharmaceuticals, Inc. Antiviral formulations
WO2017011785A1 (en) 2015-07-15 2017-01-19 National Concessions Group Inc. Topical antiviral formulations and methods of using the same
KR20260035292A (ko) * 2017-06-12 2026-03-12 레이크우드 아메덱스, 인크. 비스포스포신 겔 제제 및 이의 용도
CN114302707A (zh) 2019-06-14 2022-04-08 普洛拉治疗公司 局部阿昔洛韦制剂及其用途

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3536816A (en) * 1964-09-30 1970-10-27 Atlas Chem Ind Water-in-oil emulsion
US3592930A (en) * 1968-07-19 1971-07-13 Syntex Corp Moisture-deterioratable topical medicaments,particularly anti-inflammatory steroids,in a substantially non-aqueous fatty alcohol-propylene glycol vehicle
CH558659A (fr) * 1969-11-26 1975-02-14 Orsymonde Procede pour la preparation d'une composition lyophilisee a usage hygienique.
US3924004A (en) * 1971-11-24 1975-12-02 Syntex Corp Fatty alcohol-propylene carbonate-glycol solvent cream vehicle
ZA72698B (en) * 1972-02-03 1973-09-26 Liebenberg R W Method of preparing medicinal compositions
US3892857A (en) * 1972-11-24 1975-07-01 Squibb & Sons Inc Steroid formulation
ZA738657B (en) * 1973-01-05 1974-10-30 Hoffmann La Roche Emulsions
GB1478009A (en) * 1973-04-02 1977-06-29 Glaxo Lab Ltd Pharmaceutical compositions
US3867528A (en) * 1973-10-11 1975-02-18 American Cyanamid Co Steroidal topical cream base
GB1523865A (en) * 1974-09-02 1978-09-06 Wellcome Found Purine compunds and salts thereof
GB1543907A (en) * 1975-02-19 1979-04-11 Dermal Labor Ltd Steroid compositions
US3934013A (en) * 1975-02-21 1976-01-20 Syntex (U.S.A.) Inc. Pharmaceutical composition
US4049802A (en) * 1975-03-19 1977-09-20 Research Corporation Zinc sulfadiazine and its use in the treatment of burns
GB1554720A (en) * 1975-07-10 1979-10-24 Nyegaard & Co As Pyridthione derivatives
US4144332A (en) * 1976-01-05 1979-03-13 The Regents Of The University Of Michigan Process for alleviating proliferative skin diseases
JPS52105195A (en) * 1976-03-01 1977-09-03 Wellcome Found Substituted purine
SE7702990L (sv) * 1976-03-19 1977-09-20 Minnesota Mining & Mfg Tropiskt administreringssystem for lekemedel med forsterkt peutreringsformaga
DE2646435B2 (de) * 1976-10-14 1979-05-31 Shiseido Co., Ltd., Tokio Verfahren zur Herstellung einer stabilen Öl-in-Wasser-Emulsion
GB1556632A (en) * 1977-01-14 1979-11-28 Sterling Drug Inc Antimicrobial skin cleasing composition
US4145440A (en) * 1977-08-18 1979-03-20 The Upjohn Company Liquid suspension of an aluminum salt of ibuprofen
CA1113005A (en) * 1977-12-06 1981-11-24 Pierluigi Vanoni Excipient composition for creams
DE2847975A1 (de) * 1978-11-04 1980-05-14 Merck Patent Gmbh Verfahren zur bindung von freiem formaldehyd in pharmazeutischen und kosmetischen zubereitungen

Also Published As

Publication number Publication date
JPS5742615A (enExample) 1982-03-10
KR830005852A (ko) 1983-09-14
JPH0148885B2 (enExample) 1989-10-20
GEP19981256B (en) 1998-04-01
US4963555A (en) 1990-10-16
SU1375113A3 (ru) 1988-02-15

Similar Documents

Publication Publication Date Title
GB2078719B (en) Heterocyclic compounds
DE3172252D1 (en) Heterocyclic compounds
CY1309A (en) Formulations of heterocyclic compounds
ZA814925B (en) Formulations of heterocyclic compounds
ZA815539B (en) Heterocyclic compounds
EG17031A (en) Novel heterocyclic compounds
JPS56154464A (en) Heterocyclic compound
ZA815541B (en) Heterocyclic compounds
JPS56139484A (en) Heterocyclic compound
ZA815540B (en) Heterocyclic compounds
JPS5791986A (en) Heterocyclic compounds
IL67185A0 (en) Heterocyclic compounds
GB2083463B (en) Heterocyclic compounds
GB2083476B (en) Heterocyclic compounds
HK98088A (en) Inner salts of heterocyclic compounds
GB2074863B (en) Therapeutic compositions of physostigmine compounds
GB2082175B (en) Heterocyclic compounds
GB2078737B (en) Protection of arylmalonyl derivatives
IL67098A0 (en) Heterocyclic compounds
ZA813354B (en) Heterocyclic compounds
GB2129426B (en) Compounds of thiatriazines
JPS568359A (en) Manufacture of heterocyclic compound
ZA818703B (en) Heterocyclic compounds
GB8325760D0 (en) Heterocyclic compounds
JPS5794042A (en) Carbazolization of anthrimide